BioAffinity Technologies宣佈註冊直接發行、同時進行的定向增發和認股

快訊 · 08/06 01:17

BioAffinity Technologies Announces Closing of Registered Direct Offering, Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million

BioAffinity Technologies宣佈註冊直接發行、同時進行的定向增發和認股契約誘因結束，募集總收益爲175萬美元。